Seer Inc (SEER)
2.42
+0.10
(+4.40%)
USD |
NASDAQ |
Nov 14, 16:00
2.42
0.00 (0.00%)
After-Hours: 16:36
Seer Shareholders Equity (Quarterly): 344.73M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 344.73M |
| June 30, 2024 | 364.70M |
| March 31, 2024 | 383.56M |
| December 31, 2023 | 396.90M |
| September 30, 2023 | 405.68M |
| June 30, 2023 | 418.12M |
| March 31, 2023 | 432.99M |
| December 31, 2022 | 446.99M |
| September 30, 2022 | 457.77M |
| Date | Value |
|---|---|
| June 30, 2022 | 472.04M |
| March 31, 2022 | 486.46M |
| December 31, 2021 | 502.92M |
| September 30, 2021 | 515.20M |
| June 30, 2021 | 526.04M |
| March 31, 2021 | 535.77M |
| December 31, 2020 | 431.61M |
| September 30, 2020 | 125.54M |
| December 31, 2019 | 87.68M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
87.68M
Minimum
Dec 2019
535.77M
Maximum
Mar 2021
407.48M
Average
432.30M
Median
Shareholders Equity (Quarterly) Benchmarks
| Organogenesis Holdings Inc | 263.50M |
| Poseida Therapeutics Inc | 60.82M |
| CEL-SCI Corp | 8.473M |
| AIM ImmunoTech Inc | 6.102M |
| IGC Pharma Inc | 7.88M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 383.42M |
| Total Liabilities (Quarterly) | 38.70M |
| Current Ratio | 18.36 |